Narayan Bandekar Pharma And Energy Llp Profile
Key Indicators
- Obligation of Contribution ₹ 1.20 M
as on 13-06-2024
- Company Age 10 Year, 21 Days
- Last Filing with ROC 31 Mar 2023
About Narayan Bandekar Pharma And Energy Llp
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 1.20 M as per MCA.
- CIN/LLPIN/FCRN
AAD-0047
- Incorporation Date
03 Dec 2014
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Goa
- Company Classification
Limited Liability Partnership
Industry
Company Details
- Location
South Goa, Goa, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Narayan Bandekar Pharma And Energy Llp?
Designated Partners(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Narayan Bandekar | Designated Partner | 03-Dec-2014 | Current |
Amit Bandekar | Designated Partner | 03-Dec-2014 | Current |
Rajan Bandekar | Designated Partner | 03-Dec-2014 | Current |
Financial Performance of Narayan Bandekar Pharma And Energy Llp.
Enhance accessibility to Narayan Bandekar Pharma And Energy Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Narayan Bandekar Pharma And Energy Llp?
Unlock access to Narayan Bandekar Pharma And Energy Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Rajaram N S Bandekar And Company Private LimitedActive 51 years 3 months
Narayan Bandekar, Amit Bandekar and 1 more are mutual person
- Rajaram Bandekar (Sirigao) Mines Private LimitedActive 52 years 4 months
Narayan Bandekar, Amit Bandekar and 1 more are mutual person
- Bandekar Minerals Private LimitedActive 49 years 6 months
Narayan Bandekar and Amit Bandekar are mutual person
- Rupa Minerals Private LimitedActive 49 years 6 months
Narayan Bandekar and Amit Bandekar are mutual person
- Narayan Bandekar And Sons Private LimitedActive 38 years 10 months
Narayan Bandekar, Amit Bandekar and 1 more are mutual person
- Bandekar Industrial And Mining Screens Pvt LtdActive 44 years 8 months
Narayan Bandekar and Rajan Bandekar are mutual person
Charges (Loans)
There are no Open Charges registered against the LLP as per our records.
How Many Employees Work at Narayan Bandekar Pharma And Energy Llp?
Unlock and access historical data on people associated with Narayan Bandekar Pharma And Energy Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narayan Bandekar Pharma And Energy Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narayan Bandekar Pharma And Energy Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.